Summary
To evaluate the usefulness of a standardized commercial amplification assay for detection of hepatitis C virus (HCV) RNA, Amplicor® HCV Test (Roche), a total of 1,204 serum samples from 888 patients was examined. Seven out of 443 anti-HCV-negative samples, 638 out of 729 anti-HCV-positive samples and four out of 32 anti-HCV-indeterminate samples tested HCV RNA positive by Amplicor® in initial testing. One false-negative and five false-positive Amplicor® results were found in initial testing, giving an overall sensitivity and specificity of the Amplicor® HCV Test of 99.8% and 99.1%, respectively. Our study confirmed that the Amplicor® HCV Test is a practical, rapid, sensitive and specific assay for detection of HCV RNA. However, the results must be interpreted with some caution and with the patient's anti-HCV status and clinical data in mind.
Zusammenfassung
Ein standardisierter kommerzieller Amplifikationsassay zum Nachweis von Hepatitis C Virus (HCV)-RNA, der Amplicor® HCV Test (Roche) wurde an 1.204 Serumproben von 888 Patienten auf seine Brauchbarkeit geprüft. Sieben von 443 anti-HCV-negativen Proben und 638 von 729 anti-HCV positiven Proben sowie vier von 32 anti-HCV unbestimmten Proben ware mit Amplicor® positiv bei erster Testung. Die Ergebnisse der ersten Testung erwiesen sich in einem Fall als falsch negativ und in fünf Fällen als falsch positiv. Für den Amplicor® HCV-Test ergibt sich daraus eine Sensitivität von 99,8% und eine Spezifität von 99,1%. Unsere Studie bestätigte, daß der Amplicor® HCV-Test ein praktischer, rasch durchführbarer, sensitiver und spezifischer Test für den Nachweis von HCV RNA ist. Die Ergebnisse müssen jedoch mit Vorsicht bewertet werden, wobei immer der anti-HCV Status des Patienten und seine klinischen Daten herangezogen werden sollten.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Garson, J. A., Tedder, R. S. The detection of hepatitis C infection. Rev. Med. Virol. 3 (1993) 75–83.
Tilston, P., Morris, D. J., Klapper, P. E., Corbitt, G. Commercial assay for hepatitis C virus RNA. Lancet 344 (1994) 201–202.
Prati, D., Capelli, C., Bosoni, P., Mozzi, F., Zanella, A., Sirchia, G. Determination of hepatitis C virus RNA in the serum by the Amplicor HCV PCR kit. Vox Sang. 67 (1994) 112–114.
Zeuzem, S., Ruster, B., Roth, W. K. Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus. Z. Gastroenterol. 32 (1994) 342–347.
Seme, K., Poljak, M. Use of a commercial PCR kit for detection of hepatitis C virus. Eur. J. Clin. Microbiol. Infect. Dis. 14 (1995) 549–552.
Nolte, F. S., Thurmond, C., Fried, M. W. Preclinical evaluation of Amplicor HCV Test for detection of hepatitis C virus RNA. J. Clin. Microbiol. 33 (1995) 1775–1778.
Young, K. K. Y., Resnick, R. M., Myers, T. W. Detection of hepatitis C virus RNA by a combined reverse transcription — polymerase chain reaction assay. J. Clin. Microbiol. 31 (1993) 882–886.
Wictor, T., Jordaan, A., du Toit, R., van Halden, P. D. Laboratory experience and guidelines for avoiding false positive polymerase chain reaction results. Eur. J. Clin. Chem. Clin. Biochem. 31 (1993) 531–535.
Garson, J. A. The polymerase chain reaction and hepatitis C virus diagnosis. FEMS Microbiol. Rev. 14 (1994) 229–240.
Zaaijer, H. L., Cuypers, H. T. M., Reesink, H. W., Winkel, I. N., Gerken, G., Lelie, P. N. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341 (1993) 722–724.
Bockstahler, L. E. Overview of international PCR standardization efforts. PCR Methods Applic. 3 (1994) 263–267.
Kapoor, M., El-Reshaid, K., Al-Mufti, S., Sanad, N. A., Koshy, A. Is dialysis environment more important than blood transfusion in transmission of hepatitis C virus during hemodialysis? Vox Sang. 65 (1993) 331.
Allander, T., Medin, C., Jacobson, S. H., Grillner, L., Persson, M. A. A. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J. Med. Virol. 43 (1994) 415–419.
Sampietro, M., Badalamenti, S., Salvadori, S., Corbetta, N., Graziani, G., Como, G., Fiorelli, G., Ponticelli, C. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int. 47 (1995) 911–917.
Seme, K., Poljak, M., Žužek-Resek, S., Avšič-Županc, T. High prevalence of hepatitis C virus infection in hemodialysis patients from one dialysis unit in Slovenia. Nephron 72 (1995) 99–100.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seme, K., Poljak, M. Evaluation of the amplicor HCV test: Experiences after 1 year of routine use in a diagnostic laboratory. Infection 24, 140–143 (1996). https://doi.org/10.1007/BF01713321
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01713321